Management of Distally Extension Maxillary Atrophied Ridge With Two Different Minimal Invasive Treatment Modalities

April 20, 2023 updated by: Mohamed Elgamal, Mansoura University

Clinical and Patient- Satisfaction Outcomes During Management of Atrophied Unilateral Distally Extension Maxillary Ridge With Two Different Minimal Invasive Treatment Modalities. 1-year Randomized Controlled Clinical Trial.

This study will compare clinical and radio graphic outcomes of two minimally invasive different treatment modalities for atrophied unilateral distal extension maxillary ridges these modalities include

  1. Medially placed implant and Implant retained distal extension removable partial denture
  2. Sinus lift and long implant to support fixed screw-retained prosthesis

Study Overview

Detailed Description

Patient selection:

For this study, 40 patients were selected from the clinic of Prosthodontics Department, Faculty of Dentistry, Mansoura University.

Inclusion criteria:

The patients will be selected according to the following:

  • They have atrophied unilateral distal extension maxillary ridge and remaining alveolar bone height 6- 8 mm as verified by preoperative cone beam. They are healthy, free from any systemic diseases relating to the bone resorption (diabetes - hyperparathyroidism). This can be achieved through medical history and clinical examination by a physician and laboratory investigations.
  • Posterior maxillary alveolar ridge deficient in height, width and covered with healthy firm covering.
  • Patients are less satisfied with conventional removable partial denture.
  • Absence of maxillary sinus diseases. Exclusion criteria

Patients were not eligible for this work if any of the following criteria were met:

  • Acute or chronic sinus pathology
  • History of a sinus augmentation in the past in the relevant sinus
  • Poor dental hygiene. Smoker.
  • Compromised general health (uncontrolled diabetes, bleeding disorder….). All patient were informed about all procedures that will be done and they sign the written consent form of ethical committee in faculty of dentistry Mansoura university.

Three treatment groups will be classified randomly, as follow:

  • Group I: patients received one implant in premolar area medial to maxillary sinus and used to retain partial over-denture.
  • Group II: patient underwent sinus lift and receive screw retained prosthesis on long implant All implants were inserted using computer guided and flap-less implant surgery and conventional loading protocol was used.

Evaluation methods Clinical and radio-graphic evaluation

  1. Modified Plaque index. Assessment of plaque accumulation with a modified plaque index : Score 0: No detection of plaque, Score 1: Plaque only recognized by running a probe across the smooth marginal surface of the implant, Score 2 Plaque can be seen by a naked eye, Score 3 Abundance of soft matter.
  2. Marginal index. Assessment of bleeding tendency with a modified bleeding index : Score 0 No bleeding when a periodontal probe is passed along the margin adjacent to the implant. Score 1 Isolated bleeding spot visible, Score 2 Blood forms a confluent red line on margin, Score 3 Heavy or profuse bleeding.
  3. Attachment level. Distance from the junction implant/crown to the most apically probe able portion, in millimeters.
  4. Pocket depth. Distance between the margin and the most apically probable portion, in millimeters Assessed by insertion of a standard periodontal probe with a point diameter of 0.5 mm using a probing force of 0.5 N.
  5. Implant stability quotient. Using resonance frequency analysis b- Radio-graphic evaluation will be performed in terms of:

Vertical bone loss will be evaluated as follows:

The distance between implant plate form and first bone to implant contact will be evaluated after one year.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mansoura, Egypt, 02050
        • Faculty of Dentistry, Mansoura University Mansoura, Eldakahlia, Egypt, 35516

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The patients will be selected according to the following:

    • They have atrophied unilateral distal extension maxillary ridge and remaining alveolar bone height 6- 8mm as verified by preoperative CBCT, They are healthy, free from any systemic diseases relating to the bone resorption (diabetes - hyperparathyroidism). This can be achieved through medical history and clinical examination by a physician and laboratory investigations.
    • Posterior maxillary alveolar ridge deficient in height, width and covered with healthy firm mucosa.
    • Patients are less satisfied with conventional RPD.
    • Absence of maxillary sinus diseases.

Exclusion Criteria:

  • • Acute or chronic sinus pathology

    • History of a sinus augmentation in the past in the relevant sinus
    • Poor dental hygiene. Smoker.
    • Compromised general health (uncontrolled diabetes, bleeding disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: implant retained removable overdentures

Procedure: Long implant and partial overdentures insertion of long implants anterior to the maxillary sinus to retain partial overdentures

Device: Partial overdentures Distal extension metallic partial dentures retained by attachments to the implants

The closed sinus lift is the elevation of the sinus membrane through the osteotomy
Other Names:
  • Minimal invasive sinus lift
The crestal approach is the elevation of the sinus membrane by osteotomes, piezosurgery, or Densah burs.
Other Names:
  • Minimal invasive sinus lift
Active Comparator: implant supported fixed screw retained prosthesis

Procedure: Sinus lift and long implant performing sinus lift surgical procedure with simultaneous placement of limplants to support screw-retained prosthesis

Device: Metal ceramic prosthesis on long implants porcelain fused to metal fixed screw-retained prosthesis supported by implants

The closed sinus lift is the elevation of the sinus membrane through the osteotomy
Other Names:
  • Minimal invasive sinus lift
The crestal approach is the elevation of the sinus membrane by osteotomes, piezosurgery, or Densah burs.
Other Names:
  • Minimal invasive sinus lift

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plaque index evaluation
Time Frame: one year
measuring plaque accumulation around implants using scores Plaque will be assessed according to modified plaque index describe as follows: score 0; no plaque detected, score 1; plaque recognized only by running a probe across a smooth marginal surface of the implant, score 2; plaque can be seen by naked eye, and score 3; abundance of soft mater.
one year
Gingival index evaluation
Time Frame: one year
measuring inflammation around implants using scores Modified index will be recorded as follows: score 0; normal , score 1; mild inflammation (slight change in color & slight edema), but no bleeding on probing, score 2; moderate inflammation (redness & edema), and bleeding on probing, and score 3; sever inflammation (marked redness, edema & ulceration) with tendency to spontaneous bleeding.
one year
Probing depth evaluation
Time Frame: one year
measuring per-implant probing depth in mm. Using a calibrated plastic periodontal probe, the distance between marginal border of the and the tip of the probe was measured in mm and considered as pocket depth.
one year
Implant stability evaluation
Time Frame: one year
measuring the mobility of the implants using resonance frequency analysis Implant stability quotient) The resonance frequencies will be measured with the osstell® device (implant stability meter) and will be expressed with measurement scale (implant stability quotient).
one year
Radio graphic evaluation
Time Frame: one year

measuring bone loss around implants in mm Radio-graphs were taken using direct digital imaging system

- Marginal alveolar bone changes (vertical and horizontal bone loss) were measured at medial and distal surface of each implant in mm.

one year
Patient satisfaction
Time Frame: one year
Patient satisfaction using questionnaire (visual analogue scale) Patient satisfaction was evaluated using a questionnaire based on visual analog scale . Patients were asked to mark their answer (amount of satisfaction) on a 100-mm line (with zero refers to not satisfied at all and 100 refers to completely satisfied). The mean of the answers (length of the lines from zero to the marks in mm) for each question. complete satisfaction). The questions cover several items related to prosthesis such as: retention, stability, comfort, ease of cleaning, ease of speaking, ease of chewing, limited activities due to embarrassment, quality of bolus and was subjected to statistical analysis
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prosthetic complication
Time Frame: one year
incidence of prosthetic aspects and maintenance requirements
one year
Muscle activity
Time Frame: one year
Muscle activity measure muscles activity in amplitude using electromyographs
one year
maximum bite force
Time Frame: one year
measuring maximum bite force in newton using bite force transducers
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2021

Primary Completion (Actual)

June 17, 2022

Study Completion (Anticipated)

June 22, 2023

Study Registration Dates

First Submitted

November 17, 2022

First Submitted That Met QC Criteria

December 9, 2022

First Posted (Actual)

December 12, 2022

Study Record Updates

Last Update Posted (Actual)

April 24, 2023

Last Update Submitted That Met QC Criteria

April 20, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • A01140420

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Partial Edentulism Class 2 Due to Periodontal Disease

Clinical Trials on Closed sinus lift procedure

Subscribe